Therapy News and Research

RSS

New hope for people with therapy-resistant depression

A study at the University Clinics of Bonn and Cologne gives people with therapy-resistant depression reason for hope.

19 Apr 2007

Decrease in breast cancer incidence linked to drop in HRT

A special report in the April 19, 2007 edition of The New England Journal of Medicine concludes that the sharp decline in breast-cancer incidence in 2003, followed by a relative stabilization at a lower rater in 2004, is most likely related to the first report of the Women's Health Initiative (WHI).

19 Apr 2007

Breast cancer incidence continues to trend low in 2004

An extended analysis of cancer rates reinforces a strong association between use of hormone replacement therapy (HRT) and increased breast cancer incidence, according to research led by scientists at The University of Texas M. D. Anderson Cancer Center and published in the New England Journal of Medicine.

19 Apr 2007

ADVENTRX announces positive data from multidrug therapy with cofactor

ADVENTRX Pharmaceuticals has announced positive results from preclinical studies using a multidrug treatment regimen including ANX-510 (CoFactor) at the American Association for Cancer Research (AACR) Annual Meeting.

19 Apr 2007

Drop in HRT use linked to decrease in breast cancer rates

According to the latest report the drop in the use of hormone replacement therapy (HRT) in mid-2002, following the results of the Women's Health Initiative study (WHI), is linked with a steep decline in new breast cancer diagnoses.

19 Apr 2007

HRT responsible for 1000 deaths in Britain from ovarian cancer

In the latest scare over hormone replacement therapy (HRT) it is thought a thousand British women may have died from ovarian cancer since 1991 because they were using the therapy.

19 Apr 2007

Grave warning about the state of AIDS treatment scale-up

The new AIDS treatment access numbers released by the World Health Organization (WHO) today are a grave warning about the state of AIDS treatment scale-up.

18 Apr 2007

FDA approves new Actonel dose

The U.S. Food and Drug Administration (FDA) approved a new dose for Actonel (risedronate sodium tablets) that will give patients the option of taking one Actonel 75 mg tablet on two consecutive days, for a total of two tablets monthly, to treat and prevent their postmenopausal osteoporosis.

18 Apr 2007

Factors that dictate risk of developing primary or secondary cancer

Every day, people make assumptions, educated and not, about their risk for developing cancer.

18 Apr 2007

OncoGenex Technologies announces data from a Phase II clinical trial of OGX-011

The primary objective of this study was to assess the objective response rates (reduction in tumor size) when OGX-011 is combined with docetaxel in patients with metastatic or locally recurrent breast cancer.

18 Apr 2007

North Shore-LIJ seeks participants for liver tumor and new chemo trial

The North Shore-LIJ Health System has announced it is seeking participants for a new clinical trial that will test a new chemotherapy option for patients with liver tumors.

18 Apr 2007

New study to assess bariatric surgery in extremely overweight teens

The National Institutes of Health (NIH) has launched an observational study to evaluate the benefits and risks of bariatric surgery in adolescents.

18 Apr 2007

Nanoparticle delivery system delivers cancer-suppressing gene in M. D. Anderson trial

A cancer-suppressing gene has been successfully delivered into the tumors of stage 4 lung cancer patients via an intravenously administered lipid nanoparticle in a phase I clinical trial at The University of Texas M. D. Anderson Cancer Center.

18 Apr 2007

Immunomedics presents results on novel immunotoxin for prostate and lung cancers

Immunomedics has presented at the 2007 Annual Meeting of the American Association for Cancer Research results on the in vitro and in vivo evaluation of a novel immunotoxin, Rap-hRS7, for the potential treatment of prostate and lung cancers.

18 Apr 2007

Global Fund must fund salaries of health workers to deliver HIV, TB and malaria treatments

In this week's PLoS Medicine, a team of international health experts issue a bold call to the Global Fund to Fight AIDS, TB, and Malaria: fund the salaries of health workers or else risk a situation in which medicines for these three diseases are made available in poor countries but there are no health professionals to deliver them.

18 Apr 2007

More effective therapies for individual cancers - personalized medicine

Genetic and epigenetic variations ensure that no two people are exactly alike, and the same holds true for any two cancers.

18 Apr 2007

Towards universal access: scaling up priority HIV/AIDS interventions in the health sector

Access to antiretroviral therapy for advanced HIV infection in low- and middle-income countries continued to grow throughout 2006, with more than 2 million people living with HIV/AIDS receiving treatment in December 2006, a 54% increase over the 1.3 million people on treatment one year earlier in these countries.

18 Apr 2007

Scientists tackle cancer with different approaches

Studies presented at the 2007 meeting of the American Association for Cancer Research show how researchers are using the new, as well as the natural, to help design and test new drugs to treat cancer.

18 Apr 2007

Tests predict outcome of antibiotic therapy for infections in persons with diabetes

Researchers from the University of Washington, Rosalind Franklin University of Medicine and Science, Merck Laboratories, and Mount Sinai School of Medicine have released a study suggesting that specific laboratory and clinical tests can predict outcome of antibiotic therapy for infections in persons with diabetes.

18 Apr 2007

Polymorphisms in the glutathione S-transferase genes and treatment outcomes in acute myeloid leukemia

Levels of an enzyme involved metabolizing chemotherapy may help patients with acute myeloid leukemia (AML) to be able to better tolerate chemotherapy, according to the results of research which will be presented by Kirsten Moysich, PhD, Department of Epidemiology, Roswell Park Cancer Institute (RPCI) at the 2007 centennial meeting of the American Association for Cancer Research (AACR), April 14-18, in Los Angeles, CA.

18 Apr 2007